Cortex Pharmaceuticals, Inc. (AMEX: COR), a biopharmaceutical company, is focused on the discovery, development and commercialization of AMPAKINE molecules designed to treat human central nervous system diseases. These novel small molecule drugs represent usher a new approach to treating psychiatric disorders, neurological diseases and brain mediated breathing disorders. For further information, visit the Company’s web site at www.cortexpharm.com.
- 18 years ago
QualityStocks
Cortex Pharmaceuticals, Inc. (AMEX: COR)
Tags Rodman & Renshaw
Related Post
-
QualityStocksNewsBreaks – VERAXA Biotech AG (NASDAQ: VRXA) Expands Heidelberg R&D Facilities To Support Drug Development Pipeline
VERAXA Biotech (NASDAQ: VRXA) an emerging developer of novel cancer therapies, announced it has expanded…
-
QualityStocksNewsBreaks – Hallmark Venture Group, Inc. (OTC: HLLK) Completes Drone Technology Acquisition, Transitions to Operating Business
Hallmark Venture Group (OTC: HLLK) announced the completion of a strategic transaction that transforms the company from…
-
QualityStocksNewsBreaks – Onco-Innovations Limited (CBOE CA: ONCO) (OTCQB: ONNVF) Featured in BioMedWire Editorial on DNA Repair Cancer Therapies
This article has been disseminated on behalf of Onco-Innovations Limited and may include paid advertising. Onco-Innovations (CBOE CA: ONCO) (OTCQB: ONNVF) announced…